Search Results

Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation.

• Authors : Soegiharto R; Department of Dermatology/Allergology, University Medical Centre Utrecht, Utrecht University, Utrecht, Netherlands.; Alizadeh Aghdam M

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/administration & dosage ; Omalizumab*/Omalizumab*/Omalizumab*/adverse effects ; Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use

• Source: JAMA dermatology [JAMA Dermatol] 2024 Sep 01; Vol. 160 (9), pp. 927-935.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print

Record details

Rituximab and Omalizumab Combination Therapy for Bullous Pemphigoid.

• Authors : Le ST; Department of Dermatology, University of California, Davis, Sacramento.; Herbert S

Subjects: Omalizumab*/Omalizumab*/Omalizumab*/therapeutic use ; Pemphigoid, Bullous*/Pemphigoid, Bullous*/Pemphigoid, Bullous*/drug therapy; Humans

• Source: JAMA dermatology [JAMA Dermatol] 2024 Jan 01; Vol. 160 (1), pp. 107-109.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print

Record details

Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial.

• Authors : Chan S; Children's Allergy, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; King's College London, School of Life Course Sciences & School of Immunology & Microbial Sciences, King's Health Partners, London, United Kingdom.

Subjects: Quality of Life*; Dermatitis, Atopic/Dermatitis, Atopic/Dermatitis, Atopic/*drug therapy ; Omalizumab/Omalizumab/Omalizumab/*administration & dosage

• Source: JAMA pediatrics [JAMA Pediatr] 2020 Jan 01; Vol. 174 (1), pp. 29-37.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589544 Publication Model: Print

Record details

Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

• Authors : Tharp MD; Department of Dermatology, Rush University Medical Center, Chicago, Illinois.; Bernstein JA

Subjects: Omalizumab/Omalizumab/Omalizumab/*therapeutic use ; Remission Induction/Remission Induction/Remission Induction/*methods ; Urticaria/Urticaria/Urticaria/*drug therapy

• Source: JAMA dermatology [JAMA Dermatol] 2019 Jan 01; Vol. 155 (1), pp. 29-38.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print

Record details

Omalizumab Treatment of Vernal Keratoconjunctivitis.

• Authors : Heffler E; Unit of Respiratory Medicine and Allergology, Department of Clinical and Experimental Medicine, Azienda Ospedaliero Universitaria Policlinico-Vittorio Emanuele Hospital, University of Catania, Catania, Italy.; Picardi G

Subjects: Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*administration & dosage ; Conjunctivitis, Allergic/Conjunctivitis, Allergic/Conjunctivitis, Allergic/*diagnosis ; Conjunctivitis, Allergic/Conjunctivitis, Allergic/Conjunctivitis, Allergic/*drug therapy

• Source: JAMA ophthalmology [JAMA Ophthalmol] 2016 Apr; Vol. 134 (4), pp. 461-3.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print

Record details

Effect of Omalizumab on Symptoms of Seasonal Allergic Rhinitis: A Randomized Controlled Trial. (Original Contribution)

• Authors : Casale, Thomas B.; Condemi, John; LaForce, Craig

• Source: JAMA, The Journal of the American Medical Association. Dec 19, 2001, Vol. 286 Issue 23, p2956, 12 p.

Record details

Chronic Spontaneous Urticaria: A Review.

• Authors : Kolkhir, Pavel; Bonnekoh, Hanna; Metz, Martin

Subjects: URTICARIA; AUTOIMMUNE thyroiditis; SKIN diseases

• Source: JAMA: Journal of the American Medical Association; 11/5/2024, Vol. 332 Issue 17, p1464-1477, 14p

Record details

FDA Greenlights First Treatment for Severe Food Allergies.

• Authors : Harris, Emily

Subjects: FOOD allergy; IMMUNOGLOBULIN E; MONOCLONAL antibodiesUNITED States. Food & Drug Administration

• Source: JAMA: Journal of the American Medical Association; 3/26/2024, Vol. 331 Issue 12, p1002-1002, 1p

Record details

Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria.

• Authors : Metz, Martin; Ohanyan, Tatevik; Church, Martin K.

• Source: JAMA Dermatology; Mar2014, Vol. 150 Issue 3, p288-290, 3p

Record details

Omalizumab for Atopic Dermatitis: Overtreatment or Lifesaver?

• Authors : Wu, Ann Chen

• Source: JAMA Pediatrics; Jan2020, Vol. 174 Issue 1, p15-16, 2p

Record details